Login
Subscribe
Premarket Report
Closing Bell Roundup
About Us
Support & FAQs
Advertise
[Free] Closing Bell Roundup
Your daily review of the biggest winners & losers from the trading day, plus notable market-moving news.
Four Straight Losing Weeks, Ground Troops on Deck, and Gas at $3.91
Mar 20, 2026
Qatar Got Struck, Gold Had Its Worst Week Since 1983, and the Dow Dropped Again
Mar 19, 2026
Two Days of Green Erased in One Fed Decision and One PPI Report
Mar 18, 2026
Two Straight Green Sessions and a War That Keeps Finding New Things to Hit
Mar 17, 2026
Wall Street Sees Green Again and Jensen Huang Walks Into a Room Full of Believers
Mar 16, 2026
Triple-Digit Oil, an Airman's Worst Friday, and a Market That Keeps Absorbing Punches
Mar 13, 2026
Oil Hits Triple Digits, a Hormuz Standoff, and Stocks Take the Punch
Mar 12, 2026
Oracle Proves AI Is Real, Papa John's Gets a Buyout Bite, and Oil Won't Sit Still
Mar 11, 2026
Rare Disease Rockets, A Pharma Buyout Lands, and Railcars Hit a Wall
Mar 10, 2026
Nasdaq Leads Rebound, Biotech Sees Breakouts, and Telehealth Scores Weight-Loss Win
Mar 9, 2026
Pain at the Pump, Pain in the Payrolls, and One Biotech Gets Paid
Mar 6, 2026
Oil's Second Wind, a Grocery Gutting, and an Ethanol Glow-Up
Mar 5, 2026
Iran Talks, Bitcoin Bounce, and Big Tech Back in the Driver's Seat
Mar 4, 2026
Oil Rallies Extend, Asset Sales Unlock Value, and Margin Pressure Hits AI Play
Mar 3, 2026
Oil Shock Ignites Small Caps, Biotech Deal Fever Spreads, and Safety Concerns Slam a Drug Maker
Mar 2, 2026
Buyout Premiums Ignite IoT, AI Demand Lifts Optics, and Cash Burn Batters Solar
Feb 27, 2026
Earnings Blowouts Spark Euphoria, Guidance Fuels Optimism, and Profit Warnings Crush Clean Energy
Feb 26, 2026
Breakthrough Designation Lifts Biotech, Takeover Interest Surfaces, and Ad Disruption Rattles Retail
Feb 25, 2026
Phase 3 Success Sparks a Biotech Rally, AI Capacity Expands, and Earnings Misses Shake Confidence
Feb 24, 2026
Takeovers Spark Surge, an FDA Approval Adds Firepower, and Trial Data Derails Pharma
Feb 23, 2026
Cloud Earnings Impress, Diabetes Devices Gain Ground, and a Trial Miss Sinks Biotech
Feb 20, 2026
A Site Expansion Fuels Breakout, Fintech Turns Profitable, and EV Write-Downs Shake Earnings
Feb 19, 2026
Oncology Funding Ignites, EU Approval Expands Reach, and Tech Volatility Pressures Chips
Feb 18, 2026
Chip-Tech Momentum Builds, Buyout Premium Lifts Stock, and Dilution Fears Hit Construction
Feb 17, 2026
Engineered Crops Break Out, Gaming Margins Expand, and an AI Debut Stumbles
Feb 13, 2026
Load more